Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1-19-PDF-041-R | Other Grant/Funding Number | American Diabetes Association |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| American Diabetes Association | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this research study is to find out more about how to support young adults (ages 18-22) with type 1 diabetes as they prepare to transition from pediatric and adult endocrinology medical care.
The overarching goal of the proposed trial is to improve diabetes self-management and glycemic control in young adults and prepare them for the transition to adult endocrinology. The current application will investigate the impact of a multisystem transition preparation intervention for young adults (ages 18-22) with T1D. Twenty-five young adults and a parent will be enrolled in a 6-month transition preparation program which will use a hybrid in-person and technology delivery structure. Providers will receive training highlighting their role preparing young adults for transition and provides practical tips to use in their communication with young adults. If effective, this multisystem intervention, designed to enhance T1D self-management and increase young adults' readiness for transition to adult healthcare during this critical developmental period, has the potential to inform clinical practice guidelines.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Transition preparation program | Experimental | Transition preparation intervention for young adults with type 1 diabetes (T1D) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Transition preparation intervention | Behavioral | Young adult participants and parents will complete transition preparation sessions that include meeting with a health behavior coach for in-person sessions and review of materials sent electronically between study visits. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of sessions attended | Number of study visits (attendance) | 6 months |
| Number of session views | Number of opened electronic materials (e.g., opened messages in the patient health portal)) | 6 months |
| Program acceptability - young adult | Young adult report on satisfaction with the program via an exit survey | 9 months |
| Program acceptability - parent | Parent report on satisfaction with the program via an exit survey | 9 months |
| Program acceptability - provider | Provider report on satisfaction with the program via an exit survey | 9 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Glycemic control | Measurement of hemoglobin A1c (A1c; reported as a percentage) | Baseline to 9 months |
| Diabetes-related hospitalizations | Participant report and medical record review of count of reported diabetes-related hospitalizations and complications |
| Measure | Description | Time Frame |
|---|---|---|
| Change in diabetes self-efficacy | Participant (young adult) report on the Self-Efficacy for Diabetes Self-Management (SEDSM) | Baseline to 9 months |
| Change in diabetes quality of life | Participant (young adult) report on the Pediatric Quality of Life Diabetes Module |
Inclusion Criteria:
Both members of the youth/parent dyad must meet all eligibility criteria
Young adults
Parents
Medical providers
• provide care to patients with T1D ages 18-22 yrs in Pediatric Endocrinology at CHoR
Exclusion Criteria:
Young adults
Parents
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Laura Caccavale, PhD | Virginia Commonwealth University | Principal Investigator |
| Melanie Melanie, PhD | Virginia Commonwealth University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Children's Hospital of Richmond at Virginia Commonwealth University | Richmond | Virginia | 23298 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 9 months |
| Change in adherence to diabetes care regimen | Average of young adult and parent participant reports on the Diabetes Management Questionnaire (DMQ) | Baseline to 9 months |
| Change in transition readiness | Average of young adult and parent participant reports on the Transition Readiness Assessment Questionnaire (TRAQ) | Baseline to 9 months |
| Baseline to 9 months |
| Change in diabetes family responsibility | Average of young adult and parent participant reports on the Diabetes Family Responsibility Questionnaire (DFRQ) | Baseline to 9 months |
| Change in diabetes family conflict | Average of young adult and parent participant reports on the Diabetes Family Conflict Scale (DFCS) | Baseline to 9 months |
| Change in depression | Participant (young adult) report on the Center for Epidemiologic Studies Depression Scale (CESD) | Baseline to 9 months |
| Change in young adult diabetes distress | Participant (young adult) report on the Diabetes Distress Scale | Baseline to 9 months |
| Change in parent diabetes distress | Participant (parent) report on the Diabetes Distress Scale for Parents of Teens with T1D | Baseline to 9 months |
| Change in autonomy support | Participant (young adult) report on the autonomy support sub-scale of the Barriers to Diabetes Adherence Questionnaire | Baseline to 9 months |
| Change in problem solving | Participant (young adult) report on the Diabetes Adherence Problem Solving Questionnaire | Baseline to 9 months |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |